Literature DB >> 27109473

Response to letter from Toldo et al. on "NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective".

Arne Yndestad1, Øystein Sandanger2, Willeke M C Jong3, Pål Aukrust2, Coert J Zuurbier3.   

Abstract

Entities:  

Keywords:  inflammasome; ischemia-reperfusion; myocardial; nlrp3

Mesh：

Substances：

Year:  2016        PMID： 27109473     DOI： 10.1016/j.bbrc.2016.04.096

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  4 in total

1.  Berberine inhibits the ischemia-reperfusion injury induced inflammatory response and apoptosis of myocardial cells through the phosphoinositide 3-kinase/RAC-α serine/threonine-protein kinase and nuclear factor-κB signaling pathways.

Authors:  Lixin Wang; Hao Ma; Yan Xue; Haiyan Shi; Teng Ma; Xiaozheng Cui
Journal:  Exp Ther Med       Date:  2017-11-27       Impact factor: 2.447

2.  Prazosin protects myocardial cells against anoxia-reoxygenation injury via the extracellular signal‑regulated kinase signaling pathway.

Authors:  Lixin Wang; Yan Xue; Hao Ma; Haiyan Shi; Ling Wang; Xiaozheng Cui
Journal:  Mol Med Rep       Date:  2017-11-28       Impact factor: 2.952

3.  NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity.

Authors:  Marina Sokolova; Ivar Sjaastad; Mieke C Louwe; Katrine Alfsnes; Jan Magnus Aronsen; Lili Zhang; Solveig B Haugstad; Bård Andre Bendiksen; Jonas Øgaard; Marte Bliksøen; Egil Lien; Rolf K Berge; Pål Aukrust; Trine Ranheim; Arne Yndestad
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561

4.  Tanshinone‑IIA inhibits myocardial infarct via decreasing of the mitochondrial apoptotic signaling pathway in myocardiocytes.

Authors:  Yeqing Fang; Chengcheng Duan; Shaoyuan Chen; Zhenguo Liu; Bimei Jiang; Wen Ai; Lei Wang; Peiyi Xie; Hongcheng Fang
Journal:  Int J Mol Med       Date:  2021-07-02       Impact factor: 4.101
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.